Evidence map›Paper›PMID 30621750›Full record

ArticleGenome biology2019

An amplicon-based sequencing framework for accurately measuring intrahost virus diversity using PrimalSeq and iVar.

Nathan D Grubaugh, Karthik Gangavarapu, Joshua Quick, Nathaniel L Matteson, Jaqueline Goes De Jesus, Bradley J Main, Amanda L Tan, Lauren M Paul, Doug E Brackney, Saran Grewal and 7 more

Abstract readEvaluation Study
In one paragraph

Article in Genome biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 767 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
767citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

767 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Global Genomic Surveillance.Methods in molecular biology (Clifton, N.J.) · 2027
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

707 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Nathan D GrubaughDepartment of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, 92037, USA. nathan.grubaugh@yale.edu.
Karthik GangavarapuDepartment of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, 92037, USA. gkarthik@scripps.edu.
Joshua QuickInstitute of Microbiology and Infection, University of Birmingham, Birmingham, B15 2TT, UK.
Nathaniel L MattesonDepartment of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, 92037, USA.
Jaqueline Goes De JesusInstitute of Microbiology and Infection, University of Birmingham, Birmingham, B15 2TT, UK.
Bradley J MainDepartment of Pathology, Microbiology and Immunology, University of California, Davis, CA, 95616, USA.
Amanda L TanDepartment of Biological Sciences, College of Arts and Sciences, Florida Gulf Coast University, Fort Myers, FL, 33965, USA.
Lauren M PaulDepartment of Biological Sciences, College of Arts and Sciences, Florida Gulf Coast University, Fort Myers, FL, 33965, USA.
Doug E BrackneyDepartment of Environmental Sciences, The Connecticut Agricultural Experiment Station, New Haven, CT, 06504, USA.
Saran GrewalDepartment of Environmental Health, San Diego County Vector Control Program, San Diego, CA, 92123, USA.
Nikos GurfieldDepartment of Environmental Health, San Diego County Vector Control Program, San Diego, CA, 92123, USA.
Koen K A Van RompayCalifornia National Primate Research Center and Department of Pathology, Microbiology and Immunology, University of California, Davis, CA, 95616, USA.
Sharon IsernDepartment of Biological Sciences, College of Arts and Sciences, Florida Gulf Coast University, Fort Myers, FL, 33965, USA.
Scott F MichaelDepartment of Biological Sciences, College of Arts and Sciences, Florida Gulf Coast University, Fort Myers, FL, 33965, USA.
Lark L CoffeyDepartment of Pathology, Microbiology and Immunology, University of California, Davis, CA, 95616, USA.
Nicholas J LomanInstitute of Microbiology and Infection, University of Birmingham, Birmingham, B15 2TT, UK.
Kristian G AndersenDepartment of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, 92037, USA.ORCID 0000-0001-6431-5982

Funding

National Institute on Aging (NIA) ColonyP51OD011107 · OD · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Simon J. Atkinson · 2012 to 2026
$191.5M
Technology CoreU19AI135995 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI Kristian Graugaard Andersen · 2018 to 2026
$32.0M
Scripps Translational Science InstituteUL1TR002550 · NCATS · SCRIPPS RESEARCH INSTITUTE, THE · PI TOPOL, ERIC JEFFREY · 2018 to 2022
$28.9M
Scripps Translational Science InstituteUL1TR001114 · NCATS · SCRIPPS RESEARCH INSTITUTE, THE · PI TOPOL, ERIC JEFFREY · 2013 to 2017
$24.0M
PATHOGENESIS AND IMMUNOLOGY OF DISEASET32AI007244 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI NEMAZEE, DAVID · 1985 to 2022
$8.8M
Development of a nonhuman primate model of fetal Zika virus infection and diseaseR21AI129479 · NIAID · UNIVERSITY OF CALIFORNIA AT DAVIS · PI VAN ROMPAY, KOEN K · 2017 to 2018
$1.9M
Design of a human monoclonal antibody-informed dengue vaccineR01AI099210 · NIAID · FLORIDA GULF COAST UNIVERSITY · PI ISERN, SHARON · 2013 to 2016
$1.7M
Analysis of Zika virus emergence and functional evolution in the AmericasR21AI137690 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI ANDERSEN, KRISTIAN GRAUGAARD · 2018 to 2019
$547k
ACL HHS U01CK000516Medical Research Council MC_PC_15100Medical Research Council MR/L015080/1Medical Research Council MR/M501621/1NCATS NIH HHS UL1 TR001114NCATS NIH HHS UL1 TR002550NCATS NIH HHS UL1TR002550NCEZID CDC HHS U01 CK000516NIAID NIH HHS HHSN272201400048CNIAID NIH HHS R01 AI099210NIAID NIH HHS R21 AI129479NIAID NIH HHS R21 AI137690NIAID NIH HHS R21AI137690NIAID NIH HHS T32 AI007244NIAID NIH HHS U19 AI135995NIAID NIH HHS U19AI135995NIH HHS P51 OD011107
6 · The paper itself

Abstract

How viruses evolve within hosts can dictate infection outcomes; however, reconstructing this process is challenging. We evaluate our multiplexed amplicon approach, PrimalSeq, to demonstrate how virus concentration, sequencing coverage, primer mismatches, and replicates influence the accuracy of measuring intrahost virus diversity. We develop an experimental protocol and computational tool, iVar, for using PrimalSeq to measure virus diversity using Illumina and compare the results to Oxford Nanopore sequencing. We demonstrate the utility of PrimalSeq by measuring Zika and West Nile virus diversity from varied sample types and show that the accumulation of genetic diversity is influenced by experimental and biological systems.

Indexed as

Genetic VariationGenomicsSequence Analysis, RNAWest Nile virusZika VirusAmplicon sequencingIntrahost evolutionSNP callingViral sequencingWest NileZika

Identifiers

PMID30621750
PMCPMC6325816

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.